NCT03439423View on ClinicalTrials.gov

Control Post Endovascular Treatment of Aortic Aneurisms Through Magnetic Resonance and Ultrasound (SAFEVAR)

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

March 9, 2016

Primary Completion Date

September 12, 2022

Study Completion Date

September 12, 2022

Conditions

Abdominal Aortic Aneurism

Interventions

RADIATION

CT with contrast agent

DIAGNOSTIC_TEST

MR without contrast agent

"on 1.5-T unit, with the following sequences:~* steady-state free-precession (true-FISP)~* half-Fourier single shot spin-echo (HASTE)"

DIAGNOSTIC_TEST

Color-Doppler Ultrasound

OTHER

Questionnaire

regarding their perception of examinations

Trial Locations (1)

20097

IRCCS Policlinico San Donato, San Donato Milanese

All Listed Sponsors

lead

IRCCS Policlinico S. Donato

OTHER

NCT03439423 - Control Post Endovascular Treatment of Aortic Aneurisms Through Magnetic Resonance and Ultrasound (SAFEVAR) | Biotech Hunter | Biotech Hunter